Development and validation of prognostic gene signature for basal-like breast cancer and high-grade serous ovarian cancer

Yi Zhang(Windber Research Institute), Jianfang Liu(Windber Research Institute), Praveen Kumar(Windber Research Institute), Lori A. Sturtz(Windber Research Institute), Anupama Praveen-Kumar(Windber Research Institute), Howard H. Yang(National Cancer Institute), Maxwell P. Lee(National Cancer Institute), J. Leigh Fantacone-Campbell(Henry M. Jackson Foundation), Jeffrey A. Hooke(Henry M. Jackson Foundation), Albert J. Kovatich(Henry M. Jackson Foundation), Craig D. Shriver(Henry M. Jackson Foundation), Hai Hu(Windber Research Institute)
Breast Cancer Research and Treatment
September 2, 2020
10.1007/s10549-020-05884-z
Cited by 6Open Access
Full Text

Abstract

Related Papers

Nonparametric Estimation from Incomplete Observations
Edward L. Kaplan, Paul Meier|Springer series in statistics|1992|45.5k
Regression Models and Life-Tables
D. R. Cox|Springer series in statistics|1992|26.7k
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
Reiki Nishimura, Tomofumi Osako, Yasuyuki Nishiyama et al.|Oncology|2013|13.2k
Statistical Methods for Research Workers
Fisher, Ronald Aylmer|American Journal of Clinical Pathology|1945|11k
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Christina Curtis, Sohrab P. Shah et al.|Nature|2012|6.3k